Concepedia

Qiang Gao

QG

Statistics

Publications

18

Citations

4.2K

H-Index

16

Active since

2005

Affiliations

Sinovac Biotech(Current)

National Institutes for Food and Drug Control

Chinese Academy of Sciences

Institute of Biophysics

National Institute for Communicable Disease Control and Prevention

Qiang Gao is an author at Sinovac Biotech specializing in vaccinology, immunology, and immunization.

ORCID

Publications per year

2005–2022

18

Publications

18

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao, Linlin Bao, Haiyan Mao et al. · Science · 2020 · 1.5K citations · Full text

, , +15

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · The Lancet Infectious Diseases · 2020 · 1.5K citations · Full text

, , +17

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial

Jiangtao Lin, Jiansan Zhang, Xiao‐Ping Dong et al. · The Lancet · 2006 · 258 citations

, , +12

Safety and Immunogenicity from a Phase I Trial of Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine

Jiangtao Lin, Jiansan Zhang, Nan Su et al. · Antiviral Therapy · 2007 · 168 citations

, , +14

A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia

Eddy Fadlyana, Kusnandi Rusmil, Rodman Tarigan et al. · Vaccine · 2021 · 148 citations · Full text

, , +17

1–5 of 18